Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.
about
Use of NSAIDs in treating patients with arthritisSingle dose oral lumiracoxib for postoperative painEpidemiology and risk profile of heart failureTramadol extended-release in the management of chronic painGastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humansAdverse effects of spinal manipulation: a systematic reviewHarpgophytum procumbens for osteoarthritis and low back pain: a systematic reviewSingle-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic reviewTolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reportsNon-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic PericarditisNatural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugsPotent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte ProteotoxicityAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinNonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational StudiesDiacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEOCardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicityCyclooxygenase inhibition: between the devil and the deep blue seaInteraction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practiceCyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular riskOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IICalcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammationFaecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes.Gout and the risk for incident heart failure and systolic dysfunction.Clinical and demographic covariates of chronic opioid and non-opioid analgesic use in rural-dwelling older adults: the MoVIES project.Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityDifferences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.Cause for concern in the use of non-steroidal anti-inflammatory medications in the community--a population-based studyRheumatology and musculoskeletal medicineMetabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.Utilization of potentially inappropriate medications in elderly patients in a tertiary care teaching hospital in India.Pharmacologic management of osteoarthritis-related pain in older adults.Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention.Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.Guided Imagery for Arthritis and Other Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.Understanding the NSAID related risk of vascular events.Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue.Five easy pieces on evidence based medicine (5). Trading benefit against harm--pain relief vs. adverse effects.
P2860
Q21195252-938DDD24-1F77-438B-8301-12C68F46500AQ24242935-2BC3B9E5-3E3F-4A1C-A91E-8B1D64F9D623Q24630778-AFEF8113-BD11-4184-94B6-7D964DE0176EQ24654636-93D8EC4B-2973-471E-9B5C-AC219D8D0F54Q24669542-4DE5F519-7B6A-4A31-8FCD-59498AAC9887Q24681683-C3A1D577-D2D4-415C-9836-897715027626Q24795764-8705C072-EBFF-415D-8D8B-8FA4B951144DQ24796186-5AB74D4E-70AA-4797-9077-E25BD973E48AQ24816687-7450E509-3506-4274-BFDB-B32FB1200B9BQ26749687-7C50666F-78E0-44C3-B47C-BD1C6922737FQ27009309-DB8E178F-F03F-47EF-BED8-B8A028F273D5Q27671971-B45218A4-174C-4097-8240-0D0F62D14D7BQ27678369-F488FA73-AE09-4703-BF29-E2BBF9C5619DQ28079436-6893A8B4-1E26-4530-B7B8-1BCA56209B48Q28079515-2BE35F30-5D13-4B19-8C65-74771F8BE6D6Q28166985-D5B4DB80-329C-42AA-ABEA-4D6835148DFFQ28192790-7304B496-7B86-4612-A3A0-0D80D75D9094Q28193462-007D2148-CEA0-4FAC-83B4-1171A160E9B5Q28198746-072B805F-3D08-4196-8E56-36DD070F2E65Q28200864-5CFAB8F3-87A5-408D-817C-8BB8457CB068Q28219220-E14E9BA5-1A18-4BE1-B1F3-5D44525227F5Q28508911-0F7EA11F-2329-4999-B44B-83BCDDA28E87Q28538368-1384DCD9-FEDA-4EB8-976A-8FFB946D351BQ30481876-1B16749C-DE78-44BE-8C5F-A08757572A9CQ30505423-FF598100-207C-4FB9-AD18-ED197C905586Q33607395-B37964C9-932B-4F24-8753-6EDDB7638E92Q33678007-B1769F72-3B3F-42AC-AF08-44988AD5C172Q33906348-424D32B4-ECEF-46F5-93FC-14A423871828Q33941101-EA2A072F-BBF1-404F-9D55-5EB155F86F6AQ33953093-4539AB94-7789-4575-90E6-6D05EAE5C896Q34098905-B1FD6046-620F-4011-9ED1-BAF75415676BQ34165559-F318B7D1-DA92-4C51-80E4-946DEFF93A7AQ34221335-99BC12CA-5BD3-4998-B387-2F61D05A4708Q34257433-C5FCCD7F-7C90-40FF-BBED-94B115922B1EQ34280879-52579310-94C0-4C44-9F5B-0BBB2BCA9BC2Q34474985-364710AC-A216-4A15-A2B7-D74AC9DD449CQ34485035-A661F929-B948-4A3A-A61A-3DD6672BD04BQ34546560-D6FFFDF0-21B8-4D98-8870-73017ADEA45DQ34556489-760BAB35-5C30-4258-A531-A8331D0362ADQ34771962-A7F76AFD-FFEC-4A10-B816-13AD2951EF3C
P2860
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Consumption of NSAIDs and the ...... ognized public health problem.
@ast
Consumption of NSAIDs and the ...... ognized public health problem.
@en
type
label
Consumption of NSAIDs and the ...... ognized public health problem.
@ast
Consumption of NSAIDs and the ...... ognized public health problem.
@en
prefLabel
Consumption of NSAIDs and the ...... ognized public health problem.
@ast
Consumption of NSAIDs and the ...... ognized public health problem.
@en
P921
P1476
Consumption of NSAIDs and the ...... cognized public health problem
@en
P2093
P304
P356
10.1001/ARCHINTE.160.6.777
P407
P50
P577
2000-03-01T00:00:00Z